Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
MHTX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
businesswire.com
15 hours ago
Earnings Growth
YoY
Current
Estimates
Q2.22
N/A
-0.00
vs -0.00
Q3.22
N/A
-0.00
vs -0.00
Q4.22
N/A
-0.00
vs -0.00
Q1.23
N/A
-0.00
vs -0.00
Q2.23
N/A
-0.00
vs -0.00
Q3.23
N/A
-0.00
vs -0.00
Q4.23
N/A
-0.00
vs -0.00
Q1.24
N/A
-0.00
vs -0.00
Q2.24
N/A
-0.00
vs -0.00
Q3.24
+328060%
1.54
vs -0.00
Sales Growth
YoY
Current
Estimates
Q1.22
NA
NA vs NA
Q2.22
-18%
41K vs 50K
Q3.22
NA
9K vs NA
Q4.22
-200%
-50000.00 vs 50K
Q1.23
NA
NA vs NA
Q2.23
-100%
NA vs 41K
Q3.23
-100%
NA vs 9K
Q4.23
+104%
2K vs -50000
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Return on Equity
QoQ
Q1.22
-167%
-1.67
vs -0.03
Q2.22
+132%
1.32
vs -1.67
Q3.22
+5%
0.05
vs 1.32
Q4.22
+23%
0.23
vs 0.05
Q1.23
+20%
0.2
vs 0.23
Q2.23
+10%
0.1
vs 0.2
Q3.23
+10%
0.1
vs 0.1
Q4.23
+14%
0.14
vs 0.1
Q1.24
+17%
0.17
vs 0.14
Q2.24
+7%
0.07
vs 0.17
Institutionnal Ownership
QoQ
Q3.22
2
2
vs 1
100%
Q4.22
2
2
vs 2
NA
Q1.23
1
1
vs 2
-50%
Q2.23
1
1
vs 1
NA
Q3.23
1
1
vs 1
NA
Q4.23
1
1
vs 1
NA
Q1.24
1
1
vs 1
NA
Q2.24
1
1
vs 1
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
1
1
vs NA
NA
Quote Panel
Key Metrics
Relative Strength
MHTX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How MHTX compares to sector?
Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
OTC
Unprofitable
EPS improving
Unprofitable
EPS improving
Relative Strenght
Volume Buzz
5221%
Earning Acce
No
Dist 52w H.
92%Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available